Tortuga Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Tortuga Wealth Management's BMY Position: Q2 2026 in Review
Tortuga Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3.6% in Q2 2026, buying an estimated $26.6K and bringing the position to 13,228 shares worth $762K. The position accounts for 0.58% of the portfolio, ranked #46.
Tortuga Wealth Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $774K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tortuga Wealth Management held 13,228 shares of Bristol-Myers Squibb worth $762K as of Q2 2026.
- Tortuga Wealth Management bought 463 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.6K.
- Bristol-Myers Squibb made up 0.58% of Tortuga Wealth Management's portfolio in Q2 2026, its #46 holding.
- Tortuga Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Tortuga Wealth Management's Bristol-Myers Squibb position peaked at $774K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tortuga Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.